| Literature DB >> 26098997 |
Mélanie Bruchard1, Cédric Rebé2, Valentin Derangère2, Dieudonnée Togbé3, Bernhard Ryffel4, Romain Boidot2, Etienne Humblin1, Arlette Hamman1, Fanny Chalmin1, Hélène Berger1, Angélique Chevriaux2, Emeric Limagne1, Lionel Apetoh2, Frédérique Végran2, François Ghiringhelli2.
Abstract
The receptor NLRP3 is involved in the formation of the NLRP3 inflammasome that activates caspase-1 and mediates the release of interleukin 1β (IL-1β) and IL-18. Whether NLRP3 can shape immunological function independently of inflammasomes is unclear. We found that NLRP3 expression in CD4(+) T cells specifically supported a T helper type 2 (TH2) transcriptional program in a cell-intrinsic manner. NLRP3, but not the inflammasome adaptor ASC or caspase-1, positively regulated a TH2 program. In TH2 cells, NLRP3 bound the Il4 promoter and transactivated it in conjunction with the transcription factor IRF4. Nlrp3-deficient TH2 cells supported melanoma tumor growth in an IL-4-dependent manner and also promoted asthma-like symptoms. Our results demonstrate the ability of NLRP3 to act as a key transcription factor in TH2 differentiation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26098997 DOI: 10.1038/ni.3202
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606